Xiangwei Liu Selected Research

Ischemia

10/2017	Mitochondrial aldehyde dehydrogenase-2 deficiency compromises therapeutic effect of ALDH bright cell on peripheral ischemia.
1/2017	Aldehyde Dehydrogenase-2 Roles in Ischemic Cardiovascular Disease.
10/2015	Mitochondrial Aldehyde Dehydrogenase 2 Regulates Revascularization in Chronic Ischemia: Potential Impact on the Development of Coronary Collateral Circulation.
1/2015	Aberrant hypermethylation of aldehyde dehydrogenase 2 promoter upstream sequence in rats with experimental myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiangwei Liu Research Topics

Disease

4	Ischemia 10/2017 - 01/2015
2	Type 2 Diabetes Mellitus (MODY) 01/2019 - 01/2017
2	Atherosclerosis 01/2019 - 01/2013
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 02/2015
2	Myocardial Infarction 01/2015 - 01/2013
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2021
1	Chronic Renal Insufficiency 11/2021
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2021
1	Coronary Disease (Coronary Heart Disease) 11/2021
1	Hypoproteinemia 11/2021
1	Pneumonia (Pneumonitis) 11/2021
1	Tinnitus 01/2021
1	Lentivirus Infections 01/2019
1	Atherosclerotic Plaque (Atheroma) 01/2019
1	Thrombosis (Thrombus) 09/2018
1	Coronary Stenosis (Coronary Artery Stenosis) 09/2018
1	Hemorrhage 09/2018
1	Acute Coronary Syndrome 09/2018
1	Peri-Implantitis 01/2017
1	Reperfusion Injury 01/2017
1	Diabetes Mellitus 01/2017
1	Fatty Liver 05/2016
1	Obesity 05/2016
1	Body Weight (Weight, Body) 05/2016
1	Insulin Resistance 05/2016
1	Hypoxia (Hypoxemia) 10/2015
1	Breast Neoplasms (Breast Cancer) 03/2003
1	Carcinoma (Carcinomatosis) 03/2003

Drug/Important Bio-Agent (IBA)

4	Aldehyde DehydrogenaseIBA 01/2019 - 01/2013
2	Small Interfering RNA (siRNA)IBA 01/2019 - 03/2003
2	AldehydesIBA 10/2017 - 01/2017
2	TitaniumIBA 01/2017 - 01/2017
2	LipidsIBA 05/2016 - 01/2013
2	Mitochondrial Aldehyde DehydrogenaseIBA 10/2015 - 02/2015
1	C-Reactive ProteinIBA 11/2021
1	ElectrolytesIBA 11/2021
1	Apolipoproteins E (ApoE)IBA 01/2019
1	Semaphorin-3AIBA 01/2019
1	oxidized low density lipoproteinIBA 01/2019
1	CholesterolIBA 01/2019
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 09/2018
1	Therapeutic UsesIBA 10/2017
1	GoldIBA 01/2017
1	oil red OIBA 05/2016
1	Trans Fatty AcidsIBA 05/2016
1	Adenosine Monophosphate (AMP)IBA 05/2016
1	Lipase (Acid Lipase)FDA Link 05/2016
1	Glucose (Dextrose)FDA LinkGeneric 05/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2015
1	salicylhydroxamic acid (SHAM)IBA 01/2013
1	naoxintongIBA 01/2013
1	LDL Receptors (LDL Receptor)IBA 01/2013

Therapy/Procedure

4	Therapeutics 01/2021 - 03/2003
1	Acupuncture Therapy 01/2021
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021
1	Percutaneous Coronary Intervention 09/2018
1	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2017